Skip to main content
SpringerLink
Log in

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

To study the role of the metastasis associated protein S100A4, an osteosarcoma cell line (OHS) with a high level of this protein was transfected with a vector containing a ribozyme that degrades S100A4 mRNA and, as controls, OHS cells were transfected with the vector alone. We have followed up our previous investigation (Bjørnland et al. 1999) by a detailed investigation of these cell lines' synthesis of MMP and TIMP proteins at different cell densities. It is shown that the cell lines with a low S100A4 level produced a reduced amount of immunoreactive MMP-2 at cellular subconfluence, while at confluence there was no difference compared to the control cells. The cell lines with a reduced S100A4 level produced less of the activated form of MMP-2 (62-kDa) and less TIMP-1 than the corresponding control cells, independent of cell density. Isolated cell membranes from cell lines with a reduced S100A4 level contained less MT1-MMP, MMP-2 and TIMP-2 compared to the control cells. Activation of exogenously added proMMP-2 was less effective with the former membrane preparations. It appeared that the mechanism behind the S100A4 dependent activation of proMMP-2 varied with cell density, as SN50, a peptide inhibitor of NF-κB nuclear translocation reduced the activation of MMP-2 at low cell density, but had no effect at high cell density. Thus, one of the mechanisms by which S100A4 may exert its effect on metastasis of some tumors is by regulating the MMP-2 activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4: 197–250.

    PubMed  CAS  Google Scholar 

  2. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–4.

    Article  PubMed  CAS  Google Scholar 

  3. McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 2001; 13: 534–40.

    Article  PubMed  CAS  Google Scholar 

  4. Seiki M. Membrane-type matrix metalloproteinases. Apmis 1999; 107: 137–43.

    Article  PubMed  CAS  Google Scholar 

  5. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151–60.

    PubMed  CAS  Google Scholar 

  6. Nagase H, Enghild JJ, Suzuki K et al. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 1990; 29: 5783–9.

    Article  PubMed  CAS  Google Scholar 

  7. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 1994; 370: 61–5.

    Article  PubMed  CAS  Google Scholar 

  8. Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331–8.

    Article  PubMed  CAS  Google Scholar 

  9. Maquoi E, Noel A, Frankenne F et al. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett 1998; 424: 262–6.

    Article  PubMed  CAS  Google Scholar 

  10. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membranetype matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996; 271: 9135–40.

    Article  PubMed  CAS  Google Scholar 

  11. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267–83.

    PubMed  CAS  Google Scholar 

  12. Newby AC, Southgate KM, Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 1994; 89(1): 59–70.

    PubMed  CAS  Google Scholar 

  13. McCawley LJ, Matrisian LM. Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today 2000; 6: 149–56.

    Article  PubMed  CAS  Google Scholar 

  14. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237–41.

    Article  PubMed  CAS  Google Scholar 

  15. Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000; 57: 5–15.

    Article  PubMed  CAS  Google Scholar 

  16. Ellerbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. Bioessays 1999; 21: 940–9.

    Article  PubMed  CAS  Google Scholar 

  17. Nawrocki B, Polette M, Marchand V et al. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int J Cancer 1997; 72: 556–64.

    Google Scholar 

  18. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1998; 1448: 190–9.

    Article  PubMed  CAS  Google Scholar 

  19. Takenaga K, Nakamura Y, Sakiyama S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997; 14: 331–7.

    Article  PubMed  CAS  Google Scholar 

  20. Maelandsmo GM, Hovig E, Skrede M et al. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490–8.

    PubMed  CAS  Google Scholar 

  21. Lakshmi MS, Parker C, Sherbet GV. Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: A possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res 1993; 13: 299–303.

    PubMed  CAS  Google Scholar 

  22. Kriajevska M, Tarabykina S, Bronstein I et al. Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 1998; 273: 9852–6.

    Article  PubMed  CAS  Google Scholar 

  23. Takenaga K, Nakamura Y, Sakiyama S et al. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 1994; 124: 757–68.

    Article  PubMed  CAS  Google Scholar 

  24. Watanabe Y, Usada N, Minami H et al. Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett 1993; 324: 51–5.

    Article  PubMed  CAS  Google Scholar 

  25. Grigorian M, Andresen S, Tulchinsky E et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001; 276: 22699–708.

    Google Scholar 

  26. Bjornland K, Winberg JO, Odegaard OT et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702–8.

    PubMed  CAS  Google Scholar 

  27. Fodstad O, Brogger A, Bruland O et al. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 1986; 38: 33–40.

    PubMed  CAS  Google Scholar 

  28. Kurschat P, Zigrino P, Nischt R et al. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem 1999; 274: 21056–62.

    Article  PubMed  CAS  Google Scholar 

  29. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992; 296: 263–6.

    Article  PubMed  CAS  Google Scholar 

  30. Will H, Atkinson SJ, Butler GS et al. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996; 271: 17119–23.

    Article  PubMed  CAS  Google Scholar 

  31. Svendsrud DH, Loennechen T, Winberg JO. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts. Biochem Pharmacol 1997; 53: 1511–20.

    Article  PubMed  CAS  Google Scholar 

  32. O'Grady RL, Nethery A, Hunter N. A fluorescent screening assay for collagenase using collagen labeled with 2-methoxy-2,4-diphenyl-3(2H)-furanone. Anal Biochem 1984; 140: 490–4.

    Article  PubMed  Google Scholar 

  33. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 2000; 304: 669–80.

    Article  PubMed  CAS  Google Scholar 

  34. Hattori S, Fujisaki H, Kiriyama T, Yokoyama T et al. Real-time zymography and reverse zymography: A method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates. Anal Biochem 2002; 301: 27–34.

    Article  PubMed  CAS  Google Scholar 

  35. Han YP, Tuan TL, Wu H et al. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 2001; 114: 131–9.

    PubMed  CAS  Google Scholar 

  36. Philip S, Bulbule A, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 2001; 276: 44926–35.

    Article  PubMed  CAS  Google Scholar 

  37. Kim H, Koh G. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaBdependent pathway. Biochem Biophys Res Comm 2000; 269: 401–5.

    Article  PubMed  CAS  Google Scholar 

  38. Lin YZ, Yao SY, Veach RA et al. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14255–8.

    Article  PubMed  CAS  Google Scholar 

  39. Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 1997; 17: 6330–8.

    PubMed  CAS  Google Scholar 

  40. Wang T, Lafuse WP, Zwilling BS. NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol 2001; 167: 6924–32.

    PubMed  CAS  Google Scholar 

  41. Bauer EA, Valle KJ. Colchicine-induced modulation of collagenase in human skin fibroblast cultures. I. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol 1982; 79: 398–402.

    Article  PubMed  CAS  Google Scholar 

  42. Tamaki M, McDonald W, Del Maestro RF. Release of collagen type IV degrading activity from C6 astrocytoma cells and cell density. J Neurosurg 1996; 84: 1013–9.

    Article  PubMed  CAS  Google Scholar 

  43. Muraoka K, Nabeshima K, Kataoka H et al. Establishment of a new human urinary bladder mixed carcinoma cell line UMK-1 and its cell-density-dependent secretion of gelatinases and tissue inhibitor of metalloproteinase-1. Urol Int 1995; 54: 184–90.

    Article  PubMed  CAS  Google Scholar 

  44. Colige AC, Lambert CA, Nusgens BV, Lapiere CM. Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases. Biochem J 1992; 285 (1): 215–21.

    PubMed  CAS  Google Scholar 

  45. Bauer EA. Cell culture density as a modulator of collagenase expression in normal human fibroblast cultures. Exp Cell Res 1977; 107: 269–76.

    Article  PubMed  CAS  Google Scholar 

  46. Jo Y, Yeon J, Kim HJ, Lee ST. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem J 2000; 345: 511–9.

    Article  PubMed  CAS  Google Scholar 

  47. Uekita T, Itoh Y, Yana I et al. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001; 155: 1345–56.

    Article  PubMed  CAS  Google Scholar 

  48. Jiang A, Lehti K, Wang X et al. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 2001; 98 (24): 13693–8.

    Article  Google Scholar 

  49. Ritter LM, Garfield SH, Thorgeirsson UP. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of humanMCF-7 breast carcinoma cells. Biochem Biophys Res Comm 1999; 257: 494–9.

    Article  PubMed  CAS  Google Scholar 

  50. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80 (Suppl 8): 1529–37.

    Article  PubMed  CAS  Google Scholar 

  51. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3: 895–904.

    Article  PubMed  CAS  Google Scholar 

  52. Duffy MJ. Cancer metastasis: biological and clinical aspects. Ir J Med Sci 1998; 167: 4–8.

    Article  PubMed  CAS  Google Scholar 

  53. Ford HL, Zain SB. Interaction of metastasis associated Mts1 protein with nonmuscle myosin. Oncogene 1995; 10: 1597–605.

    PubMed  CAS  Google Scholar 

  54. Ford HL, Silver DL, Kachar B et al. Effect of Mts1 on the structure and activity of nonmuscle myosin II. Biochemistry 1997; 36: 16321–7.

    Article  PubMed  CAS  Google Scholar 

  55. Giannelli G, Falk-Marzillier J, Schiraldi O et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277: 225–8.

    Article  PubMed  CAS  Google Scholar 

  56. Koshikawa N, Giannelli G, Cirulli V et al. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000; 148: 615–24.

    Article  PubMed  CAS  Google Scholar 

  57. von Bredow DC, Nagle RB, Bowden GT et al. Cleavage of beta 4 integrin by matrilysin. Exp Cell Res 1997; 236: 341–5.

    Article  PubMed  CAS  Google Scholar 

  58. Lochter A, Galosy S, Muschler J et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997; 139: 1861–72.

    Article  PubMed  CAS  Google Scholar 

  59. Noe V, Fingleton B, Jacobs K et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114 (1): 111–118.

    PubMed  CAS  Google Scholar 

  60. Keirsebilck A, Bonne S, Bruyneel E et al. E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res 1998; 58: 4587–91.

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Rune I. Lindstad

    Present address: University College of Nord-Tromsø, Namsos, Norway

Authors and Affiliations

  1. Department of Biochemistry, Institute of Medical Biology, University of Tromsø, Tromsø, Norway

    Berit Mathisen, Rune I. Lindstad & Jan-Olof Winberg

  2. Department of Tumor Biology, The Norwegian Radium Hospital, Oslo, Norway

    Janne Hansen, Sara Ann El-Gewely & Thrina Loennechen

  3. Department of Tumor Biology, The Norwegian Radium Hospital, Oslo, Norway

    Gunhild M. Maelandsmo, Eivind Hovig & Øystein Fodstad

Authors
  1. Berit Mathisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rune I. Lindstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janne Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara Ann El-Gewely
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gunhild M. Maelandsmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eivind Hovig
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Øystein Fodstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Thrina Loennechen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jan-Olof Winberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan-Olof Winberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathisen, B., Lindstad, R.I., Hansen, J. et al. S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 20, 701–711 (2003). https://doi.org/10.1023/B:CLIN.0000006819.21361.03

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CLIN.0000006819.21361.03

Search

Navigation